Atea Pharmaceuticals
AVIR
AVIR
126 hedge funds and large institutions have $396M invested in Atea Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 42 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
-16
Holders Change %
-11.27%
% of All Funds
1.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
36
Reduced
42
Closed
38
Calls
$4.06M
Puts
$5.47M
Net Calls
-$1.41M
Net Calls Change
-$2.97M
Top Buyers
| 1 |
1
Federated Hermes
Pittsburgh,
Pennsylvania
|
$14.8M |
| 2 |
EC
2
EcoR1 Capital
San Francisco,
California
|
$45.8M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$48.6M |
| 4 |
4
BlackRock
New York
|
$47.8M |
| 5 |
5
Acadian Asset Management
Boston,
Massachusetts
|
$6.15M |
